Skip to main content

Table 2 Summary of associations in entire population

From: Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

SNP Genotypes Cases Controls OR 95% CI P
SRC-1 CC (%) 1147 (94.2) 1432 (94.9) 1   
rs1804645 CT (%) 69 (5.6) 77 (5.1) 1.11 0.80-1.56 0.510
P1272S TT (%) 2 (0.2) 0 (0.0) - - -
   [CT + TT]<-> [CC] 1.15 0.82-1.60 0.405
SRC-3 CC (%) 1089 (89.9) 1330 (89.3) 1   
rs6094752 CT (%) 116 (9.6) 152 (10.2) 0.93 0.72-1.20 0.587
C218R TT (%) 6 (0.5) 8 (0.5) 0.92 0.32-2.65 0.871
   [CT + TT]<-> [CC] 0.93 0.73-1.19 0.575
SRC-3 GG (%) 988 (80.8) 1207 (80.3) 1   
rs2230782 CG (%) 226 (18.5) 272 (18.1) 1.11 0.83-1.23 0.881
Q586H CC (%) 9 (0.7) 24 (1.6) 0.46 0.21-0.99 0.042
   [CC]<-> [GG + GC] 0.45* 0.21-0.98* 0.041*
SRC-3 AA (%) 1011 (82.7) 1240 (82.2) 1   
rs2076546 AG (%) 202 (16.5) 249 (16.5) 0.99 0.25-1.22 0.961
T960T GG (%) 9 (0.8) 20 (1.3) 0.55 0.25-1.22 0.135
   [AG + GG]<-> [AA] 0.96° 0.79-1.17° 0.702°
SMRT GG (%) 789 (66.2) 1004 (67.6) 1   
rs2229840 AG (%) 357 (30.0) 423 (28.5) 1.07 0.91-1.27 0.407
A1706T AA (%) 45 (3.8) 57 (3.9) 1.01 0.67-1.50 0.982
   [AG + GG]<-> [AA] 1.06 0.91-1.25 0.441
  1. Odds ratios (OR) with 95% confidence intervals (95% CI) and P-values. Please note that the results excluding samples (345 cases/1190 controls) that have been analysed in a previous study (14) are *OR = 0.37, 95%CI = 0.13-1.08, p = 0.059 and °OR = 1.13, 95%CI = 0.80-1.59, p = 0.491.